Exact Mass: 465.1787
Exact Mass Matches: 465.1787
Found 238 metabolites which its exact mass value is equals to given mass value 465.1787
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cisapride
In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
cisapride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
(E)-Squamosamide
(E)-Squamosamide is found in fruits. (E)-Squamosamide is isolated from branches of Annona squamosa (sugar apple). Isolated from branches of Annona squamosa (sugar apple). (E)-Squamosamide is found in fruits.
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
Squamosamide
Ala Asp Phe Asn
Ala Asp Asn Phe
Ala Phe Asp Asn
Ala Phe Asn Asp
Ala Met Met Asn
Ala Met Asn Met
Ala Asn Asp Phe
Ala Asn Phe Asp
Ala Asn Met Met
Cys Cys Ile Gln
Cys Cys Leu Gln
Cys Cys Gln Ile
Cys Cys Gln Leu
Cys Gly Met Arg
Cys Gly Arg Met
Cys Ile Cys Gln
Cys Ile Gln Cys
Cys Leu Cys Gln
Cys Leu Gln Cys
Cys Met Gly Arg
Cys Met Asn Val
Cys Met Arg Gly
Cys Met Val Asn
Cys Asn Met Val
Cys Asn Val Met
Cys Gln Cys Ile
Cys Gln Cys Leu
Cys Gln Ile Cys
Cys Gln Leu Cys
Cys Arg Gly Met
Cys Arg Met Gly
Cys Val Met Asn
Cys Val Asn Met
Asp Ala Phe Asn
Asp Ala Asn Phe
Asp Phe Ala Asn
Asp Phe Gly Gln
Asp Phe Asn Ala
Asp Phe Gln Gly
Asp Gly Phe Gln
Asp Gly Gln Phe
Asp Asn Ala Phe
Asp Asn Phe Ala
Asp Gln Phe Gly
Asp Gln Gly Phe
Glu Phe Gly Asn
Glu Phe Asn Gly
Glu Gly Phe Asn
Glu Gly Asn Phe
Glu Asn Phe Gly
Glu Asn Gly Phe
Phe Ala Asp Asn
Phe Ala Asn Asp
Phe Asp Ala Asn
Phe Asp Gly Gln
Phe Asp Asn Ala
Phe Asp Gln Gly
Phe Glu Gly Asn
Phe Glu Asn Gly
Phe Gly Asp Gln
Phe Gly Glu Asn
Phe Gly Asn Glu
Phe Gly Gln Asp
Phe Asn Ala Asp
Phe Asn Asp Ala
Phe Asn Glu Gly
Phe Asn Gly Glu
Phe Gln Asp Gly
Phe Gln Gly Asp
Gly Cys Met Arg
Gly Cys Arg Met
Gly Asp Phe Gln
Gly Asp Gln Phe
Gly Glu Phe Asn
Gly Glu Asn Phe
Gly Phe Asp Gln
Gly Phe Glu Asn
Gly Phe Asn Glu
Gly Phe Gln Asp
Gly Met Cys Arg
Gly Met Met Gln
Gly Met Gln Met
Gly Met Arg Cys
Gly Asn Glu Phe
Gly Asn Phe Glu
Gly Gln Asp Phe
Gly Gln Phe Asp
Gly Gln Met Met
Gly Arg Cys Met
Gly Arg Met Cys
Ile Cys Cys Gln
Ile Cys Gln Cys
Ile Gln Cys Cys
Leu Cys Cys Gln
Leu Cys Gln Cys
Leu Gln Cys Cys
Met Ala Met Asn
Met Ala Asn Met
Met Cys Gly Arg
Met Cys Asn Val
Met Cys Arg Gly
Met Cys Val Asn
Met Gly Cys Arg
Met Gly Met Gln
Met Gly Gln Met
Met Gly Arg Cys
Met Met Ala Asn
Met Met Gly Gln
Met Met Asn Ala
Met Met Gln Gly
Met Asn Ala Met
Met Asn Cys Val
Met Asn Met Ala
Met Asn Val Cys
Met Gln Gly Met
Met Gln Met Gly
Met Arg Cys Gly
Met Arg Gly Cys
Met Val Cys Asn
Met Val Asn Cys
Asn Ala Asp Phe
Asn Ala Phe Asp
Asn Ala Met Met
Asn Cys Met Val
Asn Cys Val Met
Asn Asp Ala Phe
Asn Asp Phe Ala
Asn Glu Phe Gly
Asn Glu Gly Phe
Asn Phe Ala Asp
Asn Phe Asp Ala
Asn Phe Glu Gly
Asn Phe Gly Glu
Asn Gly Glu Phe
Asn Gly Phe Glu
Asn Met Ala Met
Asn Met Cys Val
Asn Met Met Ala
Asn Met Val Cys
Asn Val Cys Met
Asn Val Met Cys
Gln Cys Cys Ile
Gln Cys Cys Leu
Gln Cys Ile Cys
Gln Cys Leu Cys
Gln Asp Phe Gly
Gln Asp Gly Phe
Gln Phe Asp Gly
Gln Phe Gly Asp
Gln Gly Asp Phe
Gln Gly Phe Asp
Gln Gly Met Met
Gln Ile Cys Cys
Gln Leu Cys Cys
Gln Met Gly Met
Gln Met Met Gly
Arg Cys Gly Met
Arg Cys Met Gly
Arg Gly Cys Met
Arg Gly Met Cys
Arg Met Cys Gly
Arg Met Gly Cys
Ser Ser Ser Trp
Ser Ser Trp Ser
Ser Trp Ser Ser
Val Cys Met Asn
Val Cys Asn Met
Val Met Cys Asn
Val Met Asn Cys
Val Asn Cys Met
Val Asn Met Cys
Trp Ser Ser Ser
Sulprostone
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D008600 - Menstruation-Inducing Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C78568 - Prostaglandin Analogue
Squamosamide
N-(3,5-DICHLORO-2-HYDROXY-4-METHYLPHENYL)-2-(2,4-DI-TERT-PENTYLPHENOXY)-ACETAMIDE
Haloperidol Lactate
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Bevonium metilsulfate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
(2R)-1-(Dimethylamino)-3-{4-[(6-{[2-fluoro-5-(trifluoromethyl)phenyl]amino}pyrimidin-4-YL)amino]phenoxy}propan-2-OL
[[(E)-5-[(1S,2S,8aR)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-oxidophosphoryl] phosphate
Brasiliquinone A
A carbopolycyclic compound that is (3S)-3-ethyl-6,8-dihydroxy-3,4-dihydrotetraphene-1,7,12(2H)-trione substituted at position 8 by a 3-amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl group. It is isolated from the culture broth of Nocardia brasiliensis and exhibits antibacterial activity against Gram-positive bacteria. It is also active against the multiple drug-resistant P388/ADR tumour cells.
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide
(2E)-5-[(1S,2S,4aR,8aR)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
(2E)-5-[(1R,2R,4aS,8aS)-1-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
[(1S)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
[(1R)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
1-[2-[(2R,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
1-[2-[(2S,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide
Propulsid
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].